HVA vs IA/DA or VA in the Treatment of ND HR-AML

Clinical trial NCT06810791 · RECRUITING

Trial details

NCT number: NCT06810791
Sponsor: Nanfang Hospital, Southern Medical University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Newly Diagnosed Acute Myeloid Leukemia With High Risk

Start date: 2025-01-01
Primary completion: 2026-06-30
Enrollment: 876

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.